Caricamento...
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Chromosomal translocations are critically involved in the molecular pathogenesis of B-cell lymphomas, and highly recurrent and specific rearrangements have defined distinct molecular subtypes linked to unique clinicopathological features(1,2). In contrast, several well-characterized lymphoma entitie...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902849/ https://ncbi.nlm.nih.gov/pubmed/21368758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature09754 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|